Brief: Medartis Increases FY Revenue By 18% (Cer) To CHF 183 Mln

Medartis Holding AG

14/03/2023 05:36

March 14 (Reuters) - Medartis Holding Ag  MEDA.S :
    * MEDARTIS INCREASES REVENUE BY 18% (CER) TO CHF 183 MILLION
AND
CONTINUES TO INVEST IN FUTURE GROWTH
    * MEDARTIS EXPECTS ACCELERATED ORGANIC SALES GROWTH OF
15-18% AND
EBTIDA MARGIN TO IMPROVE TO 13-15% FOR 2023
    * REPORTED 2022 NET LOSS OF CHF 5.8 MILLION (EPS -0.49)
REFLECTS
ONE-OFF COSTS FROM US INTEGRATION AND CLOSURE IN CHINA
    * STAKE IN KERIMEDICAL TO BE INCREASED TO 47%
    * MEDARTIS HOLDING - EBITDA MARGIN IN 2022 DECREASED TO 8.9%
    * MEDARTIS AIMS TO EXPAND ITS UNDERLYING EBITDA MARGIN TO
13%-15%
IN 2023
    * FY EBITDA 16.2 MILLION CHF

Source text for Eikon:  ID:nEQ3f92GLa 
Further company coverage:  MEDA.S 

 ((Reuters.Briefs@thomsonreuters.com;))